An experimental therapy using human embryonic stem cells to treat degenerative eye diseases has proved safe and effective in animal studies, and may begin early human trials in the next few months if it receives approval from the Food and Drug Administration. If granted approval, the therapy will be the second embryonic-stem-cell-based treatment to progress to human trials, and it will provide a test case for further applications of stem cells.
A Stem-Cell Therapy for Blindness
An influenza outbreak has reportedly sickened more than 150 recruits in training at Lackland air force...
On Wednesday, the New York Knicks overcame a 29-point deficit to defeat the San Antonio Spurs...
A provision in last year’s One Big Beautiful Bill Act blocked Planned Parenthood’s health centers from...
